Industry Biotechnology
A.I.dvisor tells us that PHAR and IBRX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHAR and IBRX's prices will move in lockstep.
Ticker / NAME | Correlation To PHAR | 1D Price Change % | ||
---|---|---|---|---|
PHAR | 100% | -1.24% | ||
IBRX - PHAR | 27% Poorly correlated | -6.33% | ||
IMMP - PHAR | 24% Poorly correlated | -3.80% | ||
VERU - PHAR | 22% Poorly correlated | +11.19% | ||
CTXR - PHAR | 22% Poorly correlated | -4.02% | ||
NTRB - PHAR | 21% Poorly correlated | +15.44% | ||
More |